OWP Pharmaceuticals, Inc. received FDA approval on September 16, 2025, for its generic version of the antiepileptic drug LAMOTRIGINE targeting epileps...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
# FDA Approves AstraZeneca's KOSELUGO (selumetinib) for Neurofibromatosis Type 1 AstraZeneca Pharmaceuticals LP has received FDA approval for KOSELUG...
Eisai Inc. announced Friday the FDA approval of the subcutaneous lecanemab (Leqembi) formulation, expanding the treatment accessibility for early Alzh...
On August 28, 2025, Validus Pharmaceuticals received FDA approval for Lopressor (metoprolol tartrate), which the company characterized as a substantia...
First Nation Group, LLC secured FDA approval for its generic version of DIVALPROEX SODIUM on August 12, 2025, targeting the oral formulation previousl...
# FDA Approves Boehringer Ingelheim's HERNEXEOS (Zongertinib) for Oral Administration Boehringer Ingelheim Pharmaceuticals has received FDA approval ...
The FDA on August 8, 2025, approved Voriconazole Oral Suspension (ANDA211598) from Camber Pharmaceuticals, Inc., positioning the company to capture si...
Following the FDA’s August 7 approval of generic Gabapentin, Stallion Laboratories Private Limited adds a new player to a crowded and highly competiti...
# FDA Approves Spironolactone Generic from Camber Pharmaceuticals Camber Pharmaceuticals, Inc. received FDA approval for its generic spironolactone o...
Alembic Pharmaceuticals Inc. secured FDA approval on July 25, 2025, for its generic Carbamazepine oral tablet, enabling the company to expand its mark...
LEO Pharma, Inc. received FDA approval for the topical delgocitinib formulation under the brand name ANZUPGO, marking a strategic expansion of its por...
DR REDDYS LABS SA has secured FDA approval for its Abbreviated New Drug Application (ANDA215276), signaling a pivotal expansion of its generic portfol...
Renegeron Pharmaceuticals, Inc. has achieved a pivotal approval, according to the U.S. Food and Drug Administration, with market implications expected...
Alembic Pharmaceuticals Limited announced on Friday, June 27, 2025, the approval of an ANDA by the U.S. FDA for doxorubicin hydrochloride injection, a...
# FDA Approves ANDA Application for TP ANDA Holdings TP ANDA Holdings received FDA approval for ANDA219509 on June 23, 2025, potentially strengthenin...
Dr. Reddys Laboratories Inc. has secured FDA approval for its ANDA82176 generic version of Qsymia (phentermine and topiramate extended-release), enter...
NUVATION BIO announced Tuesday that the FDA has accepted its new drug application for its lead immune-oncology asset, a critical step that catalyzes t...
Fresenius Kabi USA, LLC announced on June 9 a new FDA approval for rocuronium bromide, potentially revitalizing the generic neuromuscular blockers mar...
Azurity Pharmaceuticals secured FDA approval Friday for WIDAPLIK (telmisartan, amlodipine and indapamide), a new oral antihypertensive. This launch st...
Devatis Inc. secured FDA approval for its oral Lenalidomide generic, positioning the manufacturer to capture potential market share in the myeloma tre...